Director of the Board

Per Antonsson (Swedish, born 1960) joined PILA PHARMA AB in 2015 as ALMI Invest’s representative in the Board of Directors. Per is a scientist by training with significant experience from both academia and drug development in the biotech segment and has significant experience in company start-ups including financing.

Per Antonsson holds a BSc of Biochemistry and analytical sciences and a PhD from the University of Lund (1991) and has held several research positions in Pharma/Biotech from 1994-2000 including Pharmacia and Pharmacia & Upjohn and is the author of several scientific publications.

Besides, Per Antonsson has served as business advisor at Teknopol, AB in Sweden (2000-2010) facilitating company start-up in life science university spin-offs and has served as Investment Manager at ALMI Invest AB in Sweden since 2010.

Per Antonsson currently holds Director of the Boards positions in Sweden in Speximo AB, Evince AB, Simply Dental AB and previously in Simrisalg AB, Saromics Biostructure AB, Nattaro Labs AB, United Pancakes AB, DRSK Development AB, Pampett AB, Serstech AB, Senzodetect AB, Pronas Pharma AB, Medtentia AB and Orbichem AB.